Zydus Cadila begins human trials of its potential vaccine fo
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Zydus Cadila, on July 15 said that it has begun giving its potential coronavirus vaccine (ZyCoV-D) to healthy volunteers in the first and second phases of human clinical trials across multiple sites.

"Zydus has already manufactured clinical GMP batches of the vaccine candidate and plans to initiate the clinical trials in July 2020 across multiple sites in India in over 1000 subjects," the company said.

As per the Clinical Trial Registry of India (CTRI) data which was updated on July 4, the phase-1 where the vaccine will be tested for safety is expected to be completed in 84 days, and phase-2 where the vaccine will be tested for safety, efficacy, will compared with placebo and it is expected to take 84 days.

In the pre-clinical phase, the vaccine was found to elicit a strong immune response in multiple animal species like mice, rats, guinea pigs and rabbits.

The antibodies produced by the vaccine were able to neutralize the wild type virus in virus neutralization assay indicating the protective potential of the vaccine candidate.

Source: https://www.moneycontrol.com/news/trends/health-trends/zydus-cadila-begins-human-trial-of-its-potential-vaccine-for-coronavirus-5549321.html
Dr. R●●●●a S●●●a and 9 others like this2 shares
Like
Comment
Share
Dr. P●●●●●●●●n A●●●●●●●●●n
Dr. P●●●●●●●●n A●●●●●●●●●n Nephrology
Both phase 1 and 2 started simultaneously or only phase 1
Jul 16, 2020Like